PRETORIA (Reuters) - South Africa's central bank paused its rate-cutting cycle on Thursday as risks stemming from U.S.
Alvotech acquires Xbrane’s R&D operations and the biosimilar candidate XB003. Xbrane retains some pre-clinical development programs, that it intends to commercialize, and will continue operating as a ...
The approval also cleared the way for the brewing giant to take over the import business of Distell International Limited in ...
Goldman Sachs downgraded its recommendation on South African equities to "marketweight" from "overweight" on Thursday, saying ...
2024 Adjusted EBITDA of $117.2M, Net Income attributable to Orezone shareholders of $55.7M and Earnings per Share attributable to Orezone shareholders of $0.14 and $0.13 on a basic and diluted basis, ...
After being named 2024 College Dux and receiving the prestigious Anthony Family Trophy, Douglas Shire local Tully Smith ...